Document is current
Any future updates will be listed below
-
Authors
Musmar, Basel
Salim, Hamza Adel https://orcid.org/0000-0002-5208-8425
Adeeb, Nimer
Yedavalli, Vivek
Lakhani, Dhairya
El Naamani, Kareem
Henninger, Nils
Sundararajan, Sri Hari
Kühn, Anna Luisa
Khalife, Jane
Ghozy, Sherief
Scarcia, Luca
Tan, Benjamin Y. Q.
Regenhardt, Robert W.
Heit, Jeremy J.
Cancelliere, Nicole M.
Bernstock, Joshua D.
Rouchaud, Aymeric
Fiehler, Jens
Sheth, Sunil
Puri, Ajit S.
Dyzmann, Christian
Colasurdo, Marco
Barreau, Xavier
Renieri, Leonardo
Filipe, João Pedro
Harker, Pablo
Radu, Răzvan Alexandru
Abdalkader, Mohamad
Klein, Piers
Marotta, Thomas R.
Spears, Julian
Ota, Takahiro
Mowla, Ashkan
Jabbour, Pascal
Biswas, Arundhati
Clarençon, Frédéric
Siegler, James E.
Nguyen, Thanh N.
Varela, Ricardo
Baker, Amanda
Essibayi, Muhammed Amir
Altschul, David
Gonzalez, Nestor R.
Möhlenbruch, Markus A.
Costalat, Vincent
Gory, Benjamin
Stracke, Christian Paul
Aziz-Sultan, Mohammad Ali
Hecker, Constantin
Shaikh, Hamza
Liebeskind, David S.
Pedicelli, Alessandro
Alexandre, Andrea M.
Tancredi, Illario
Faizy, Tobias D.
Kalsoum, Erwah
Lubicz, Boris
Patel, Aman B.
Pereira, Vitor Mendes
Guenego, Adrien
Dmytriw, Adam A.
,
Amllay, Abdelaziz
Vagal, Achala
ter Schiphorst, Adrien
Thomas, Ajith J.
Gopinathan, Anil
Dusart, Anne
Capirossi, Carolina
Mounayer, Charbel
Weyland, Charlotte
Hsieh, Cheng-Yang
Griessenauer, Christoph J.
Stapleton, Christopher J.
Bellante, Flavio
Marnat, Gaultier
Forestier, Géraud
Cuellar-Saenz, Hugo H.
Valente, Iacopo
Sibon, Igor
Rabinov, James D.
Berge, Jérôme
Jesser, Jessica
Martinez-Gutierrez, Juan Carlos
Premat, Kevin
Yeo, Leonard LL.
Chervak, Lina
Meyer, Lukas
Elhorany, Mahmoud
Quintero-Consuegra, Miguel
- License Information
-
More Information
Article History
Received: 12 March 2024
Accepted: 4 November 2024
First Online: 15 January 2025
Declarations
:
: The study received approval from the local ethical standards committee at each participating site, and informed consent from patients was waived. The data supporting this study’s findings are available from the corresponding author upon reasonable request.
: Dr. Regenhardt serves on a DSMB for a trial sponsored by Rapid Medical, serves as site PI for studies sponsored by Penumbra and Microvention, and receives stroke research grant funding from the National Institutes of Health, Society of Vascular and Interventional Neurology, and Heitman Stroke Foundation.Dr. Guenego reports consultancy for Rapid Medical and Phenox, not directly related to the present work.Dr. Clarençon reports conflicts of interest with Medtronic, Balt Extrusion (consultant), ClinSearch (core lab), Penumbra, Stryker (payment for reading) and Artedrone (Board); all not directly related to the present work.Dr. Henninger received support from W81XWH-19-PRARP-RPA form the CDMRP/DoD, NS131756 and U24NS113844 from the NINDS, and NR020231 from the NINR and received compensation from Myrobalan, Inc. and General Dynamics during the conduct of this study unrelated to this work.Dr. Liebeskind is consultant as Imaging Core Lab to Cerenovus, Genentech, Medtronic, Stryker, Rapid Medical.Dr. Yeo reports Advisory work for AstraZeneca, Substantial support from NMRC Singapore and is a medical advisor for See-mode, Cortiro and Sunbird Bio, with equity in Ceroflo. All unrelated to the present work.Dr. Griessenauer reports a proctoring agreement with Medtronic and research funding by Penumbra.Dr. Marnat reports conflicts of interest with Microvention Europe, Stryker Neurovascular, Balt (consulting), Medtronic, Johnson & Johnson and Phenox (paid lectures), all not directly related to the present work.Dr. Puri is a consultant for Medtronic Neurovascular, Stryker NeurovascularBalt, Q’Apel Medical, Cerenovus, Microvention, Imperative Care, Agile, Merit, CereVasc and Arsenal Medical, he received research grants from NIH, Microvention, Cerenovus, Medtronic Neurovascular and Stryker Neurovascular, and holds stocks in InNeuroCo, Agile, Perfuze, Galaxy and NTI.Dr. Tjoumakaris is a consultant for Medtronic and Microvention (funds paid to institution, not personally).Dr. Jabbour is a consultant for Medtronic, Microvention and Cerus.
